ArticleScientific reports2019

Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway.

Ryan Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.